Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

By Maas K.W.   van der Lee I.   Bolt K.   Zanen P.   Lammers J.W.J.   Schramel F.M.N.H.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite

Increasing the Dose Intensity of Chemotherapy by Means of Granulocyte-colony Stimulating Factor (G-CSF) Support in the Treatment of Small Cell Lung Cancer (SCLC)

By Girling D.J.   Thatcher N.   Clark P.I.   Stephens R.J.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1263-1263

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Somatostatin Receptor Imaging of Small Cell Lung Cancer (SCLC) by Means of 111 In-DTPA Octreotide Scintigraphy

By Bombardieri E.   Crippa F.   Cataldo I.   Chiti A.   Seregni E.   Soresi E.   Boffi R.   Invernizzi G.   Buraggi G.L.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 184-188

Elsevier

Access to resources Recommend Favorite

Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) Apoptosis In Vitro

By Yang Xiaohan   Xiong Hai   Guan Zhu-zhu   Okai Isaac   Ye Dongmei   Song Yang   Li Xiao   Wang Lan   Liu Lu   Du Sha   Lin Dongmei   Shao Shujuan  

Cancer Investigation, Vol. 30, Iss. 6, 2012-06 ,pp. : 453-462

Informa Healthcare

Access to resources Recommend Favorite